CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

June 11th, 2010

FDA Announces Ongoing Safety Review of Olmesartan

The FDA announced an ongoing safety review of olmesartan (Benicar). The agency said it “has not concluded that Benicar increases the risk of death” and advises patients and healthcare professionals that it “currently believes that the benefits of Benicar in patients with high blood pressure continue to outweigh its potential risks.” The review was prompted by unexpected findings in the ROADMAP and ORIENT clinical trials of an increased number of cardiovascular deaths in patients taking olmesartan compared to placebo.

Categories: General


You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.